為肺癌第一期病患制定復發預測模型

吳玉琮, 魏念之, 洪榮志, 葉奕成, 蘇立仁, 周德盈, 許文虎
臺北榮民總醫院病理科, 國立陽明大學臨床醫學研究所, 國立中央大學高通量實驗分析核心設施, 優化生技 Oncotarget. 2017; 8:79712-79721

By |2018-09-16T00:08:11+00:0029 8 月, 2018|醫學期刊|在〈為肺癌第一期病患制定復發預測模型〉中留言功能已關閉

為早期結直腸癌患者建立個人化治療計劃

林楨國, 姜正愷, 周德盈, 魏念之, 林宏鑫, 林春吉, 藍苑慈, 張世慶, 王煥昇, 楊純豪, 陳維熊, 林資琛 臺北榮民總醫院, 國立陽明醫學院, 優化生技
DOI: 10.18632/oncotarget.14638

By |2017-10-08T19:01:55+00:001 2 月, 2017|醫學期刊|在〈為早期結直腸癌患者建立個人化治療計劃〉中留言功能已關閉

Prediction of chemotherapeutic response in ovarian cancer with DNA microarray expression profiling

Zachariah E. Selvanayagam, Tak Hong Cheung, Nien Wei, Ragini Vittal, Keith Wing Kit Lo, Winnie Yeo, Tsunekazu Kita, Roald Ravatn, Tony Kwok Hung Chung, Yick Fu Wong, Khew-Voon Chin Cancer Genetics and Cytogenetics, Volume 154, Issue 1, Pages 63-66 (1 October 2004)

By |2018-09-25T18:48:52+00:0014 3 月, 2016|醫學期刊|在〈Prediction of chemotherapeutic response in ovarian cancer with DNA microarray expression profiling〉中留言功能已關閉

The development of complete personalized treatment plans for colon cancer patients utilizing three gene prediction models.

Jeng-Kai Jiang, Hung-Shin Lin, Jen-Kou Lin, Yu-Chung Wu, Teh-Ying Chou, Nien Wei; Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan; Taipei Veterans General Hospital, Taipei, Taiwan; Auspex Diagnostics, Taipei, Taiwan
2014 ASCO Annual Meeting

By |2017-03-14T04:34:10+00:0014 3 月, 2016|醫學期刊|在〈The development of complete personalized treatment plans for colon cancer patients utilizing three gene prediction models.〉中留言功能已關閉

Comparison of genomic signatures of non-small cell lung cancer recurrence between two microarray platforms

Chang JW1, Wei NC, Su HJ, Huang JL, Chen TC, Wu YC, Yu CT, Hou MM, Hsieh CH, Hsieh JJ, Wu CE, Cheng HY, Hsu T, Wang TH. Division of Hematoloy-Oncology, Genomic Medicine Research Core Lab, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan, ROC. Anticancer Research April 2012 vol. 32 no. 4 1259-1265

By |2018-09-25T18:50:10+00:0024 4 月, 2012|醫學期刊|在〈Comparison of genomic signatures of non-small cell lung cancer recurrence between two microarray platforms〉中留言功能已關閉